Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
286.49B
Market cap286.49B
Price-Earnings ratio
15.85
Price-Earnings ratio15.85
Dividend yield
2.84%
Dividend yield2.84%
Average volume
9.11M
Average volume9.11M
High today
$116.80
High today$116.80
Low today
$114.38
Low today$114.38
Open price
$115.80
Open price$115.80
Volume
7.95M
Volume7.95M
52 Week high
$125.14
52 Week high$125.14
52 Week low
$73.31
52 Week low$73.31

Stock Snapshot

The current Merck(MRK) stock price is $115.95, with a market capitalization of 286.49B. The stock trades at a price-to-earnings (P/E) ratio of 15.85 and offers a dividend yield of 2.8%.

On 2026-03-18, Merck(MRK) stock moved within a range of $114.38 to $116.80. With shares now at $115.95, the stock is trading +1.4% above its intraday low and -0.7% below the session's peak.

Trading volume for Merck(MRK) stock has reached 7.95M, versus its average volume of 9.11M.

Over the past 52 weeks, Merck(MRK) stock has traded between a high of $125.14 and a low of $73.31.

Over the past 52 weeks, Merck(MRK) stock has traded between a high of $125.14 and a low of $73.31.

MRK News

Simply Wall St 21h
Merck ACC.26 Data Highlights Cardio Pulmonary Pipeline Beyond Keytruda

Merck (NYSE:MRK) plans to present new cardiopulmonary data at ACC.26, including the first Phase 3 results for its oral PCSK9 inhibitor enlicitide. The company...

Merck ACC.26 Data Highlights Cardio Pulmonary Pipeline Beyond Keytruda
TipRanks 2d
Merck announces new clinical data from cardio-pulmonary pipeline

Merck (MRK) announced new clinical data from the company’s cardio-pulmonary pipeline will be presented at the American College of Cardiology’s Annual Scientific...

Simply Wall St 2d
Merck Readies For Keytruda Cliff With New Drivers And mRNA Vaccines

Merck, NYSE:MRK, has outlined a broad plan to limit the revenue impact as Keytruda approaches loss of exclusivity. The company is targeting more than 20 new hu...

Merck Readies For Keytruda Cliff With New Drivers And mRNA Vaccines

Analyst ratings

61%

of 31 ratings
Buy
61.3%
Hold
38.7%
Sell
0%

More MRK News

Simply Wall St 4d
A Look At Merck Valuation As Recent Gains Contrast Conflicting Fair Value Estimates

Merck (MRK) is back on investors’ radar after recent trading left the shares around $115.91, with short term returns mixed, while the past 3 months and year hav...

A Look At Merck Valuation As Recent Gains Contrast Conflicting Fair Value Estimates
Seeking Alpha 5d
Dividend Roundup: Microsoft, Meta Platforms, Merck & Co., Target, and more

This week's dividend activity included increased payouts from Colgate-Palmolive (CL) and Applied Materials (AMAT) as declarations from companies such as Microso...

Dividend Roundup: Microsoft, Meta Platforms, Merck & Co., Target, and more

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.